Importantly, SMURF1 is increased in the tissues of patients with PAH and Smurf1 deletion protects mice from PAH (64), indicating a critical role of SMURF1 and its degradation targets in disease development. The gene discussed is SMURF1; the disease is pulmonary arterial hypertension.